Akash Sabarwal

7PUBLICATIONS
15CO-AUTHORS
Molecular targetsChemotherapyMedical molecular engineering of nucleic acids and proteinsPlant pathologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 23, 2026
Inhibition of PLK1 helps to restrict c-Met-induced growth and therapeutic resistance of renal cancer cells.

|Sep 29, 2025
Honokiol in cancer: Roles in enhancing combination therapy efficacy and preventing post-transplant malignancies.

Laxminarayan Rawat, Raghu Solanki, Rahul Kumar

|Feb 09, 2025
AXL signaling in cancer: from molecular insights to targeted therapies.

Monika Yadav, Akansha Sharma, Ketki Patne

|Sep 30, 2023
Aminoacyl-tRNA synthetase - a molecular multitasker.

Swadha Gupta, Jaykumar Jani, Vijayasurya

|Nov 24, 2022
A novel 4'-brominated derivative of fisetin induces cell cycle arrest and apoptosis and inhibits EGFR/ERK1/2/STAT3 pathways in non-small-cell lung cancer without any adverse effects in mice.

Akash Sabarwal, Jaco C van Rooyen, Jeremy Caburet

|May 13, 2022
Plumbagin induces ROS-mediated apoptosis and cell cycle arrest and inhibits EMT in human cervical carcinoma cells.

Ankita Jaiswal, Akash Sabarwal, Jai Prakash Narayan Mishra

Pageof 2

Frequent Collaborators

2 joint publications

Rana P Singh

1 joint publications

Willem A L van Otterlo

1 joint publications

Swadha Gupta

1 joint publications

Jaykumar Jani